BI-SPECIFIC MONOVALENT DIABODIES THAT ARE CAPABLE OF BINDING CD123 AND CD3, AND USES THEROF

• 收藏
• 分享

专利权人:

INC.;MACROGENICS

发明人:

BONVINI, EZIO,JOHNSON, LESLIE, S.,HUANG, LING,MOORE, PAUL, A.,CHICHILI, GURUNADH, REDDY,ALDERSON, RALPH, FROMAN

申请号：

SG11201601317U

公开号：

SG11201601317UA

申请日:

2014.08.20

申请国别(地区):

SG

年份:

2016

代理人:

摘要：

The present invention is directed to sequence-optimized CD 123 x CD3 bi-specific monovalent diabodies that are capable of simultaneous binding to CD123 and CD3, and to the uses of such diabodies in the treatment of hematologic malignancies.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/